Verapamil for Neuroprotection in Stroke

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 20, 2017

Primary Completion Date

August 31, 2026

Study Completion Date

December 31, 2026

Conditions
Ischemic Stroke
Interventions
DRUG

10 mg Intra-arterial Verapamil

Intra-arterial delivery of verapamil following mechanical thrombectomy procedure will be administered at a randomized dose of 10 mg or 20 mg to consenting patients.

DRUG

20 mg Intra-arterial Verapamil

Intra-arterial delivery of verapamil following mechanical thrombectomy procedure will be administered at a randomized dose of 10 mg or 20 mg to consenting patients.

Trial Locations (3)

19013

COMPLETED

Crozer Chester Medical Center, Upland

19047

NOT_YET_RECRUITING

St Mary Medical Center, Langhorne

08401

RECRUITING

AtlantiCare Regional Medical Center, Atlantic City

Sponsors
All Listed Sponsors
lead

Global Neurosciences Institute

OTHER